Going forward..., page-1180

My thoughts are that tale over will not occur YET or if it does then the premium paid will have to be large .
Blocking stakes in register .
I hope that Fuji GvHD Exercise will occur and a premium for other applications ( hence the taken time )
I also wouldn’t be surprised ( and hopeful ) that another significant player ( or institution ) come on to the register .
A placement would not be a bad thing .

We know free funding has been secured for phase 2 trials in some applications. Don’t think for a minute that the NRMC ( govt body - maybe not quite the initials ) didn’t do due diligence before giving a grant .
All the above give the company validation as a significant provider to the stem cell world .

Don’t forget as our market cap grows then we will be on the radar and have to be included in index funds holdings .
Do I have a price target ?
No but I can pretty confidently say over time ( with ups and downs ) that it will be much much higher